APOE Genotype Modifies the Relationship between Midlife Vascular Risk Factors and Later Cognitive Decline
Katherine J. Bangen, Alexa Beiser, Lisa Delano-Wood, Daniel A. Nation, Melissa Lamar, David J. Libon, Mark W. Bondi, Sudha Seshadri, Philip A. Wolf and Rhoda Au
Journal of stroke and cerebrovascular diseases, v 22(8), pp 1361-1369
aging Apolipoprotein E cardiovascular disease cognition diabetes hypertension vascular risk
Vascular risk factors have been associated with cognitive decline; however, it remains unclear whether apolipoprotein E (APOE) genotype modifies this relationship. We aimed to further elucidate these relationships and extend previous findings by examining data from a more comprehensive cognitive assessment than used in prior studies.
In all, 1436 participants from the prospective Framingham Offspring Cohort Study underwent health examination from 1991 to 1995, followed by a baseline neuropsychological assessment (1999-2003) and a repeat neuropsychological assessment approximately 8 years later (2004-2009). Multivariate linear regression analyses were performed to examine the relationship among midlife vascular risk factors, presence of the APOE ε4 allele, and cognitive change.
APOE genotype significantly modified the associations between both midlife hypertension and cardiovascular disease and decline in language abilities and midlife diabetes and decline in verbal memory, attention, and visuospatial abilities. Associations between increased midlife vascular risk burden and greater cognitive decline were observed among APOE ε4 carriers but not noncarriers.
The present findings revealed a subgroup at increased risk for cognitive decline (APOE ε4 carriers with midlife exposure to vascular risk factors) and suggest that treatment of vascular risk factors during midlife may reduce the risk of cognitive impairment later in life, particularly among APOE ε4 carriers.
APOE Genotype Modifies the Relationship between Midlife Vascular Risk Factors and Later Cognitive Decline
Creators
Katherine J. Bangen - University of California, San Diego
Alexa Beiser - Boston University
Lisa Delano-Wood - University of California - San Diego School of Medicine
Daniel A. Nation - VA San Diego Healthcare System
Melissa Lamar - University of Illinois at Chicago
David J. Libon - Drexel University
Mark W. Bondi - VA San Diego Healthcare System
Sudha Seshadri - Boston University
Philip A. Wolf - Framingham Heart Study
Rhoda Au - Framingham Heart Study
Publication Details
Journal of stroke and cerebrovascular diseases, v 22(8), pp 1361-1369
Publisher
Elsevier
Number of pages
9
Grant note
K24 AG26431, T32 MH 19934-17, P30 AG013846, R01 AG12674, AG08122, AG16495, AG033193, and AG031287 / National Institutes of Health
N01-HC-25195 / NIH/NHLBI
Framingham Heart Study's National Heart, Lung, and Blood Institute
Resource Type
Journal article
Language
English
Web of Science ID
WOS:000327719000101
Scopus ID
2-s2.0-84889074196
Other Identifier
991021901012104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Domestic collaboration
Web of Science research areas
Neurosciences
Peripheral Vascular Disease
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services